A three-way comparative genomic analysis of Mannheimia haemolytica isolates

Paulraj K Lawrence1, Weerayuth Kittichotirat, Jason E McDermott

  • 1Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040, USA. pklawrence@vetmed.wsu.edu

BMC Genomics
|October 6, 2010
PubMed
Abstract

Insights

Mannheimia haemolytica causes significant cattle losses. Genomic analysis revealed unique genes and high-confidence SNPs, offering new targets for understanding pathogenesis and developing control strategies for this important bovine respiratory disease agent.

Area of Science:

  • Bacteriology
  • Genomics
  • Veterinary Medicine

Background:

  • Mannheimia haemolytica is a primary cause of bovine respiratory disease complex, leading to substantial economic losses in the U.S. beef industry.
  • This Gram-negative bacterium transitions from commensal to pathogen under stress, causing acute pleuropneumonia (shipping fever).
  • Current understanding of M. haemolytica pathogenesis and epidemiology is limited by the absence of specific genetic markers.

Purpose of the Study:

  • To identify novel genetic markers for M. haemolytica.
  • To explore molecular targets for understanding pathogenesis and developing control strategies.
  • To investigate genomic variations within M. haemolytica strains.

Main Methods:

  • Comparative genomic sequence analysis of three M. haemolytica isolates.
  • Identification of strain-unique genes and high-confidence single nucleotide polymorphisms (hcSNPs).
  • Focus on non-synonymous SNPs within known virulence genes for potential array design.

Main Results:

  • Discovery of previously unknown type III secretion effector proteins.
  • Identification of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) sequences.
  • Detection of various adhesins with immuno-dominant domains.

Conclusions:

  • The identified unique genes and hcSNPs are valuable targets for future research into M. haemolytica virulence and regulation.
  • The potential presence of a type III secretion system necessitates re-evaluation of host-pathogen interaction studies.
  • Adhesins with immuno-dominant domains represent promising candidates for vaccine development against M. haemolytica infections.